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OBJECTIVE—Current studies indicate that Hedgehog (Hh)
signaling must be excluded during early stages of pancreas
formation. However, conﬂicting evidence suggests that Hh sig-
naling may be active later during pancreas formation and that it
is required for insulin production and secretion in cultured -cell
lines. The objective of this study was to address these discrep-
ancies by assessing the in vivo role of epithelial Hh signaling in
the pancreas.
RESEARCH DESIGN AND METHODS—To identify Hh-active
cells in the developing and adult pancreas epithelium, we char-
acterized transgenic reporter Patched1-LacZ mice. To determine
the requirement for epithelial Hh signaling in the pancreas, we
eliminated an essential Hh signaling component, Smoothened
(Smo), in the pancreatic epithelium, and assessed pancreatic
development and adult -cell physiology phenotypes.
RESULTS—Characterization of Patched1-LacZ reporter mice
revealed low-level LacZ expression in pancreatic epithelial cells
throughout development until birth, when LacZ activity increases
in intensity speciﬁcally in endocrine and ductal cells. In the
absence of Hh signaling, Smo-deﬁcient mice have delayed pan-
creas formation leading to a temporary reduction in pancreatic
epithelium and -cell numbers. Although -cell numbers re-
cover by birth, adult Smo-deﬁcient mice display glucose
intolerance, increased insulin sensitivity, and reduced total
insulin production.
CONCLUSIONS—These data show that Hh signaling functions
early during pancreas morphogenesis to regulate epithelial and
-cell expansion and to modulate glucose metabolism by regu-
lating insulin production in adult mice. Diabetes 59:1211–
1221, 2010
T
he advancements in stem cell technologies carry
the promise toward developing a renewable sup-
ply of -cells and a cure for diabetes. While
signiﬁcant progress has been made in recent
years, there is still a need for a greater understanding of
the signals that inﬂuence pancreas and endocrine differ-
entiation and function. To address this issue, we set out to
deﬁne the role of the Hedgehog (Hh) signaling pathway in
the pancreas epithelium and in -cell formation and
function.
Starting at about embryonic day 9.0 (e9.0) in mice, the
pancreatic epithelium expands into the surrounding mes-
enchyme (1). The initial budding of the dorsal epithelium
is followed by ventral epithelial budding 1 day later.
Subsequently, the epithelial buds branch and differentiate
into the exocrine acini and ducts, which produce and
collect the digestive enzymes necessary for nutrient ab-
sorption, and the endocrine islets, which produce hor-
mones essential for glucose utilization and storage. During
this process, the pancreatic epithelium and mesenchyme
compartments communicate with each other through the
release of soluble signals that bind to their respective
receptors expressed on target cells (2,3).
One pathway known to relay signals between epithelial
and mesenchymal cells is the Hh signaling pathway, which
is involved in morphogenesis and cell differentiation in
many organs during embryogenesis. In mammals, three
secreted ligands, Sonic Hh (Shh), Indian Hh (Ihh), and
Desert Hh (Dhh), activate Hh signaling through Smooth-
ened (Smo), a G-protein coupled receptor (GPCR)-like
protein. Activation of Smo occurs when Hh ligands bind
the receptor Patched1 (Ptch1), initiating activation of Hh
target gene expression through the family of Gli transcrip-
tion factors. Notably, some known Hh target genes include
Hh signaling components themselves, including Ptch1 and
Gli1. While a number of other molecules have been
characterized in the pathway, a more comprehensive
explanation of their function is well described in several
recent reviews (4–7).
Previous studies have demonstrated how Hh signaling
affects pancreas formation. Characterization of Hh gene
expression showed that Shh is expressed throughout the
endoderm epithelium but is strikingly excluded from the
speciﬁed pancreatic region, suggesting an inhibitory role
of the protein in pancreas organogenesis (8). Indeed, this
conclusion was supported in several studies (9–12) where
models of activated Hh signaling resulted in loss of pan-
creatic tissue with a corresponding gain of tissues with
duodenal properties. Interestingly, the varying level of Hh
activation achieved in these models may correlate to
varying differences in pancreas-to-duodenal conversion
phenotypes, thus suggesting a dose dependent response to
Hh activation. Complementary loss-of-Hh-activation stud-
ies (13–15) demonstrate that inactivation leads to an
expansion of pancreatic area. Thus, these studies indicate
that Hh signaling acts to limit pancreatic growth.
Despite the evidence that overt Hh signaling blocks
pancreas organogenesis, several studies have demon-
strated a positive role for Hh signaling in the pancreas. In
the developing pancreas, Ihh and Dhh ligands and Ptch1
receptor are expressed from e13.5 and onward in the
developing pancreas and the adult islet and ductal tissues
(13,16). Furthermore, studies by Thomas and colleagues in
2000 and 2001 (16,17) indicate that Hh signaling function-
ally supports insulin production and secretion by regulat-
ing Pdx1 expression in INS1 cells. Thus, these ﬁndings
suggest a bimodal role for Hh signaling, with low-level
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endocrine function while overt activation inhibits organo-
genesis. However, previous studies failed to address the
cellular requirements for Hh signaling in the epithelial
versus the mesenchymal compartments. As Hh signaling
has been shown to differentially modulate epithelial and
mesenchymal development in other contexts, a closer
examination of the role of Hh signaling in either compart-
ment is needed.
In this study, we investigated the effects of loss of Hh
signaling in the epithelium during development and in the
postnatal islet. By employing Ptch1-LacZ transgenic mice,
a reporter line that marks cells with active Hh signaling,
we ﬁrst demonstrate that Hh is active within the pancre-
atic epithelium. Second, to address the functional role of
epithelial Hh signaling, we used Pdx1-Cre
early mice to
generate transgenic mice lacking Smo function speciﬁcally
in the pancreas epithelium. Results from these studies
show that epithelial-speciﬁc Smo loss results in delayed
expansion of the early pancreatic epithelium and delayed
-cell morphogenesis. While -cell numbers recover by
birth, Smo mutant mice are glucose intolerant and pro-
duce less insulin despite increased -cell mass. Thus, our
studies demonstrate a requirement for epithelial Hh sig-
naling both during formation of the embryonic pancreas
epithelium as well as in the maintenance of endocrine
function.
RESEARCH DESIGN AND METHODS
Generation of mice. STOCK-Ptch1
tm1Mps/J mice were obtained from The
Jackson Laboratories. 129X1-Smo
tm1Amc/J mice (Smoothened null) and
STOCK-Smo
tm2Amc/J mice (Smoothened ﬂoxed) mice were obtained from
Andrew McMahon (Harvard University, Cambridge, MA) and crossed with
Pdx1-Cre
early mice from Doug Melton (Harvard University, Cambridge, MA)
to generate Pdx1-Cre
early;Smo
ﬂox/null mice. Control samples were either
Smo
ﬂox/ﬂox or Smo
ﬂox/wildtype.
Tissue preparation, immunohistochemistry, and microscopy. Embryonic
and adult tissues were ﬁxed in 4% paraformaldehyde and parafﬁn wax
embedded as previously described (10). A description of antibodies used is in
the online appendix RESEARCH DESIGN AND METHODS (available at http://
diabetes.diabetesjournals.org/cgi/content/full/db09-0914/DC1).
Quantiﬁcation of markers. Tissues were harvested, ﬁxed, and processed as
described above. Quantiﬁcation of markers was performed as previously
described (10).
Patched-LacZ stains. Tissues harvested from STOCK-Ptch1
tm1Mps/J mice at
various embryonic dates were ﬁxed and stained as described in the online
appendix RESEARCH DESIGN AND METHODS.
Islet isolation. Islets were isolated with help from the University of
California San Francisco Diabetes Center Islet Production Facility Core
according to their protocol. Three to six mice per cohort were used for each
islet isolation procedure.
RNA isolation, Sybr Green, and Taqman real0time quantitative PCR.
RNA from isolated islets and microdissected pancreatic buds was prepared
according to the Qiagen Qiashredder and RNAEasy Micro protocols. cDNA
was transcribed according to BioRad iScript Kit instructions. Real-time PCR
was performed as previously described (10,18) using Sybr Green Fast Univer-
sal mix or Taqman Fast Universal Mixes from Applied Biosystems. See online
appendix RESEARCH DESIGN AND METHODS for additional data analysis details and
Supplemental Table 1 for primer sequences.
Glucose and insulin tolerance tests. Mice were fasted for 14–16 h
overnight and assayed as previously described (19) using 2 g/kg glucose and
1 unit/kg insulin, respectively.
Total insulin content. Mouse pancreata were harvested in 2 mol/l acetic
acid, homogenized, and assayed for total content according to the Alpco
Ultrasensitive Mouse Insulin ELISA Kit.
Calculation of -cell mass. Total -cell mass from whole pancreata was
calculated as previously described (19).
In vitro islet insulin secretion assay. Three replicates consisting of two
mice per isolation of control (Smo
ﬂox/ﬂox) versus mutant (Pdx1-Cre
early;
Smo
ﬂox/null) were analyzed. For each isolation, 10 size-matched islets were
collected per sample (in ﬁve replicates) and incubated in RPMI media with
low (30 mg/dl) or high (300 mg/dl) glucose and with or without 40 mmol/l
potassium chloride (KCl) for 1 h before media were collected and assayed
according to the Alpco Ultrasensitive Mouse Insulin ELISA Kit.
RESULTS
Hh-active cells exist within the developing and adult
pancreas. Despite intensive research, the absence of
reliable antibodies to detect signaling components in
tissue sections has left the characterization of Hh-active
cells within the pancreas unclear. To determine whether
pancreatic cells display active Hh signaling, we stained
developing and adult pancreata from Patched1-LacZ
(Ptch1-LacZ) transgenic mice. In these mice, the bacterial
b-galactosidase (b-gal) gene has replaced the endogenous
Ptch1 coding sequence, and its activity is controlled by the
regulatory elements of the Ptch1 locus (20). Since Ptch1
itself is a transcriptional target gene of Hh signaling, b-gal
activity marks Hh active cells. We found b-gal–positive
cells in the pancreatic epithelium as early as e10.5 (Fig.
1A–D, arrowheads). Notably, we also detected a few cells
in the adjacent mesenchyme with punctate b-gal staining
(Fig. 1C and D, arrows). Between e12.5 and e17.5, we
observed a progressive increase in b-gal–positive cells
(Fig. 1E–P), with cells conﬁned to the endocrine and
ductal epithelium after birth (Fig. 1Q–Z). Remarkably,
postnatal b-gal–positive cells were marked by a qualita-
tively more robust signal throughout the cell. Thus, our
results demonstrate that Hh-active cells reside in the early
pancreatic epithelium, as well as in the adult endocrine
and ductal lineage.
Loss of Hh signaling in Pdx1-Cre
early;Smo
ﬂox/null pan-
creas. Smo, an essential mediator of Hh signaling, initiates
Gli transcriptional activity in all Hh-active cells. Tissue-
speciﬁc elimination of Smo function has been shown to
block ligand-induced Hh signaling (21–24). Using the same
strategy, we decided to use Pdx1-Cre
early mice to elimi-
nate the ﬂoxed allele of Smo in the pancreatic epithelium.
Earlier work by our group has shown that Pdx1-Cre
early
mice induce efﬁcient Cre-mediated recombination
throughout the pancreatic epithelium by e10.5 (25). To
conﬁrm that Pdx1-Cre
early;Smo
ﬂox/null pancreata had
efﬁciently recombined the ﬂoxed Smo allele, we stained
pancreata for Smo protein expression. Similar to Ptch1-
LacZ expression, Smo staining in Smo
ﬂox/wildtype or
Smo
ﬂox/ﬂox control tissues was undetectable by immuno-
staining in the exocrine pancreas (not shown) but present
in insulin-expressing cells at P0 (Fig. 2A, C, and E). In
contrast, Smo protein was efﬁciently eliminated in Pdx1-
Cre
early;Smo
ﬂox/null mutants (Fig. 2B, D, and F), a ﬁnding
supported by quantitative PCR that detected a 70% down-
regulation of Smo gene expression in adult islets (Fig. 2G)
and e12.5 whole pancreatic buds (data not shown). Com-
plete elimination of Smo expression by quantitative PCR is
not expected as the Cre line does not induce recombina-
tion in the surrounding mesenchyme or other nonpancre-
atic cell types (e.g., endothelial and neural cells) within
the isolated pancreatic islet or tissue. To verify that
elimination of Smo resulted in downregulation of Hh
signaling, we performed quantitative PCR to analyze the
expression of Hh target genes, Gli1 and Ptch1, and
found their expression dramatically and signiﬁcantly
downregulated in Pdx1-Cre
early;Smo
ﬂox/null adult islets
(Fig. 2H and I). Thus, we conclude that Pdx1-Cre
early;
Smo
ﬂox/null mice have strong reduction in Hh signaling in
the pancreatic epithelium.
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FIG. 1. Hedgehog-active cells reside in the developing and adult pancreas. Pancreatic tissue was isolated from either control mice at e10.5 (A),
e12.5 (E), e15.5 (I), e17.5 (M), postnatal day 0 (P0) (Q), and 2 weeks (U), or Patched1-LacZ (Ptch1-LacZ) transgenic mice at e10.5 (B–D), e12.5
(F–H), e15.5 (J–L), e17.5 (N–P), P0 (R–T), 2 weeks (V–X), and 4 weeks (Y–Z’). -Gal activity was marked by blue staining pattern highlighted
by arrowheads and/or arrows. Arrowheads  Ptch1-LacZ staining in the epithelium; arrows  Ptch1-LacZ staining in the mesenchyme. Scale bars
in A and B, E and F, I and J, and M and N are equal to 50 m, while scale bars in Q and R, and U and V, are equal to 100 m. Lastly, the scale
bar in Y is equal to 200 m. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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early;Smo
ﬂox/null pancreata show disrupted
pancreas morphogenesis. Previous loss-of-function
studies suggested that widespread reduction of Hh signal-
ing in the epithelium and mesenchyme results in an
expansion of the pancreatic domain and a relative increase
in endocrine area (13–15). To determine whether down-
regulated Hh signaling in the pancreatic epithelium alone
had similar effects, we analyzed the pancreatic epithelium
during early pancreas formation. Control and mutant
Pdx1-Cre
early;Smo
ﬂox/null embryos were harvested at e12.5,
and whole pancreata were stained with anti-Pdx1 and
anti-Nkx6.1 antibodies to mark pancreatic epithelial cells.
Staining for Pdx1 and Nkx6.1 revealed that cellular differ-
entiation was unaffected as all epithelial cells were posi-
tive for both markers (Fig. 3A and B). Next, we assessed
pancreas morphology and size by histological analysis of
whole pancreata. In contrast to previous reports that
correlate inhibition of overall Hh signaling with increased
pancreas size, we found that the pancreatic epithelial area
was decreased by nearly 60% at e12.5 in Pdx1-Cre
early;
Smo
ﬂox/null mutants (Fig. 3C). Furthermore, the epithelium
appeared more disorganized, suggesting that epithelial
branching was disrupted (Fig. 3A). Consecutive serial
sections of e12.5 pancreatic epithelium more clearly dem-
onstrated that epithelial expansion and branching were
disrupted (supplemental Fig. 1A–F). The disruption in
expansion and branching is temporary, as by e15.5 total
pancreatic epithelial area normalized (Fig. 3C) and
showed no gross abnormalities at birth. Recovery of total
pancreatic epithelial area by e15.5 may be due to changes
in cell proliferation or cell death. To determine whether
these processes were altered at this stage, we stained
e15.5 tissues with either phospho-histone H3 to mark
proliferating cells or for cleaved caspase 3 to mark apo-
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FIG. 2. Pdx1-Cre
early;Smo
ﬂox/null mice have downregulated Smo expression and Hh signaling. Smoothened (green) and insulin (red) costaining in
control (A, C, and E) and Pdx1-Cre
early;Smo
ﬂox/null (B, D, and F) P0 islets. Scale bars are equal to 10 m. G: Smoothened gene expression by Sybr
green real-time PCR is downregulated in islets isolated from Pdx1-Cre
early;Smo
ﬂox/null mice vs. control islets (n  3; ***P < 0.005). Expression
of Hh target genes Gli1 (H) and Patched1 (I) is reduced compared with controls (n  4; ***P < 0.005). P values were determined by Student t
test. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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ber of proliferating epithelial cells in Pdx1-Cre
early;
Smo
ﬂox/null mutant pancreata (Fig. 3D), while the number
of apoptotic cells was unchanged (Fig. 3E). Thus, recovery
of total pancreatic epithelial area by e15.5 is due to
increased epithelial proliferation.
To address the mechanism of early epithelial loss in
Pdx1-Cre
early;Smo
ﬂox/null pancreata, we examined the ef-
fect decreased Hh signaling had on other developmental
signaling pathways. From e10 to e11.5, Fgf10 is secreted
from the mesenchyme and promotes expansion of pancre-
atic progenitor populations (26–29). Although previous
work from our lab showed that increased Hh signaling in
embryos mutant for the Hh inhibitor Hhip (Hhip
/)
reduces Fgf10 expression in the mesenchyme, and impairs
pancreatic epithelial growth and branching (10), it is
unclear whether changes speciﬁcally in epithelial Hh sig-
naling secondarily impact mesenchyme function and Fgf10
expression. To determine whether epithelial Hh signaling
is required for mesenchymal Fgf10 expression, we per-
formed quantitative PCR on mesenchyme-intact e10.5 and
e11.5 Pdx1-Cre
early;Smo
ﬂox/null pancreata but detected no
changes in expression level (supplemental Fig. 2A). Be-
sides ﬁbroblast growth factor (FGF) signaling, Wnt and
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FIG. 3. Early pancreas formation in Pdx1-Cre
early;Smo
ﬂox/null mice is perturbed. Sections stained with Pdx1 (green), Nkx6.1 (red), and DAPI
(blue) staining in e12.5 pancreata show disrupted pancreatic branching in control (A) vs. Pdx1-Cre
early;Smo
ﬂox/null (B) mice. Scale bars are equal
to 100 m. (Arrowheads in A and B indicate branching tips.) C: Total pancreatic epithelial area is reduced in Pdx1-Cre
early;Smo
ﬂox/null mice at
e12.5 but normalized by e15.5. (n  4 for e12.5 samples; **P < 0.02; n  6 for e15.5 samples). D: Recovery of total pancreatic epithelial area
at e15.5 is due to increased total epithelial cell proliferation, as measured by phospho-histone H3 (n  5; ***P < 0.005). E: The apoptotic rate
in e15.5 total pancreatic epithelium is not changed in Pdx1-Cre
early;Smo
ﬂox/null mice (n  3). P values were determined by Student t test. (A
high-quality digital representation of this ﬁgure is available in the online issue.)
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also interact with Hh signaling to regulate organ formation
and differentiation (25,30–36). In particular, we have
shown previously that stabilization of -catenin early
during organogenesis results in a severe loss of pancreatic
epithelium and increased epithelial expression of Hh li-
gands (25). To determine whether cell autonomous loss of
Hh signaling affected expression of Wnt, BMP, or Hh
ligands at this stage, we performed quantitative PCR for
soluble factors in these signaling pathways in e10.5 and
e11.5 pancreata. While expression of some Wnt ligands and
soluble factors suggested that Wnt signaling might be in-
creased at e10.5, expression of Wnt target genes was not
altered (supplemental Fig. 2C and D). In addition, we did not
detect signiﬁcant changes in gene expression levels for BMP
or Hh ligands (supplemental Fig. 2B and E). Therefore, we
conclude that reduction in Hh signaling in the epithelium
results in delayed epithelial expansion, while mesenchymal
signaling appears unchanged during early pancreatogenesis.
Pdx1-Cre
early;Smo
ﬂox/null pancreata show disrupted
-cell morphogenesis. Next, we assessed the effects of
downregulated Hh signaling on endocrine and -cell de-
velopment. Grossly, exocrine, duct, and endocrine differ-
entiation appeared normal. However, upon closer
examination of endocrine areas, we found that -cell area
was diminished at e15.5. Quantiﬁcation of -cell and -cell
areas revealed that while the relative -cell area was
normal, the relative -cell area was reduced by 45% at
e15.5 (Fig. 4A, B, and E). Interestingly, the decrease in
-cell area recovered to normal levels by birth (Fig. 4F).
We hypothesized that increased -cell proliferation and/or
neogenesis could account for the recovery in -cell area.
A B
C
R
e
l
a
t
i
v
e
 
R
a
t
i
o
 
R
e
l
a
t
i
v
e
 
R
a
t
i
o
 
F 
E 
H I 
Control   
N
e
u
r
o
g
e
n
i
n
3
/
N
k
x
6
.
1
 
I
n
s
u
l
i
n
/
G
l
u
c
a
g
o
n
  ** 
Control 
 
E15.5 Endocrine Area 
P0 Endocrine Area 
** 
0 
0.5 
1 
1.5 
2 
2.5 
R
e
l
a
t
i
v
e
 
R
a
t
i
o
 
0 
0.5 
1 
1.5 
2 
2.5 
0 
0.8 
0.6 
0.4 
0.2 
1 
1.5 
0 
0.8 
0.6 
0.4 
0.2 
1 
1.2 
1.4 
R
e
l
a
t
i
v
e
 
R
a
t
i
o
 
E15.5 E15.5 
# Total Ngn3
cells 
# Ngn3/Nkx6.1
cells 
0 
10 
20 
30 
40 
50 
e15.5 P0 
Rel Gluc Area Rel Tot Endo
Area
Rel Ins Area
Rel Gluc Area Rel Tot Endo
Area
Rel Ins Area
#
P
H
3
/
I
n
s
u
l
i
n
 
C
e
l
l
s
 
G
* 
Pdx1-Creearly;Smoflox/null
Pdx1-Creearly;Smoflox/null
D
FIG. 4. Pdx1-Cre
early;Smo
ﬂox/null mice have delayed -cell formation. Insulin (green) and glucagon (red) staining in e15.5 pancreata show an
approximate equivalent number of -cells (140 -cells in control vs. 130 -cells in mutant samples) but a reduced number of -cells (144 -cells
in control vs. 95 -cells in mutant samples) between control (A) and Pdx1-Cre
early;Smo
ﬂox/null (B) mice. Neurogenin3 (Ngn3) (green) and Nkx6.1
(red) staining in e15.5 control (C) and Pdx1-Cre
early;Smo
ﬂox/null (D) pancreata. Scale bars in A–D are equal to 100 m. Quantiﬁcation of
endocrine areas at e15.5 and P0 show that while glucagon areas are normal, insulin area is reduced at e15.5 (E) but normalizes by P0 (F)i n
Pdx1-Cre
early;Smo
ﬂox/null mice (n  3 for e15.5 samples; **P < 0.02; n  4 for P0 samples). G: Proliferation measured by phospho-histone H3 does
not account for -cell recovery at e15.5 or P0 (n  4; *P < 0.05). While analysis of Ngn3 (green)/Nkx6.1 (red) positive cells in control (C) and
Pdx1-Cre
early;Smo
ﬂox/null (D) mice show no signiﬁcant change in the number of total Ngn3 positive cells (H), a 71% increase in the number of
Ngn3/Nkx6.1 positive progenitor -cells (I) is observed at e15.5 (n  6; **P < 0.02). P values were determined by Student t test. (A high-quality
digital representation of this ﬁgure is available in the online issue.)
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analyze cell proliferation. We found that the number of
proliferating insulin cells was reduced at e15.5 but normal
at P0 (Fig. 4G). Therefore, early increased proliferation of
-cells could not account for the documented recovery at
P0 but may contribute to reduced -cell numbers at e15.5.
To determine whether -cell neogenesis was affected, we
examined neurogenin 3 (Ngn3) expression in control
versus Pdx1-Cre
early;Smo
ﬂox/null mice. Ngn3 is a transcrip-
tion factor expressed during endocrine cell fate speciﬁca-
tion, and cells that express Ngn3 and Nkx6.1 are a deﬁned
population of immature -cell progenitors. While the total
number of Ngn3-expressing cells was unchanged (Fig.
4H), we found that the number of immature Ngn3/Nkx6.1
double-positive -cell progenitors were increased by 71%
in Pdx1-Cre
early;Smo
ﬂox/null mice at e15.5 (Fig. 4I). To-
gether, these results indicate that a higher proportion of
-cell progenitors remain midway through pancreas devel-
opment, suggesting that -cell formation is either pro-
longed or delayed. To differentiate between these two
processes, we characterized the gene expression pattern
of Ngn3 from e12.5 through e16.5 by quantitative PCR.
Although we did not ﬁnd signiﬁcant changes in Ngn3
expression levels (supplemental Fig. 3), we observed a
trend toward a delayed peak in Ngn3 expression from
e13.5 to e14.5 in Pdx1-Cre
early;Smo
ﬂox/null mice. Moreover,
Ngn3 expression at e16.5 is signiﬁcantly higher in Pdx1-
Cre
early;Smo
ﬂox/null than control mice, consistent with a
delayed differentiation of -cells (supplemental Fig. 3).
Summarily, our results show an early delay in pancreas
growth and branching followed by a transient delay in
-cell formation upon inhibition of Hh signaling in
Pdx1-Cre
early;Smo
ﬂox/nullmice.
Adult Pdx1-Cre
early;Smo
ﬂox/null pancreata have im-
paired -cell function. In vitro studies (16,17) have
suggested that Hh signaling plays a role in insulin produc-
tion and secretion in insulinoma-derived -cell lines. To
determine whether reduction of Hh signaling affects adult
pancreas and -cell function in vivo, we performed histo-
logical and physiological analyses in adult Pdx1-Cre
early;
Smo
ﬂox/null pancreata. Histological analysis did not reveal
any morphological differences between control and Pdx1-
Cre
early;Smo
ﬂox/null pancreata by hematoxylin and eosin
staining (Fig. 5A and B), and we observed normal expres-
sion of endocrine, exocrine, and ductal markers (Fig.
5C–J). Thus, adult pancreas and islet morphology is indis-
tinguishable from wild-type tissue.
To determine whether loss of Hh signaling impacts
-cell physiology, we challenged Pdx1-Cre
early;Smo
ﬂox/null
mice to respond to a glucose load. Despite the absence of
morphological defects, Pdx1-Cre
early;Smo
ﬂox/null mice
were glucose intolerant by 3 months of age (Fig. 6A), a
defect that progressively worsened with age (data not
shown). Glucose intolerance can be caused by defects in
insulin resistance in peripheral tissues or defects in insulin
production/secretion in -cells. To determine whether
Pdx1-Cre
early;Smo
ﬂox/null mice are insulin resistant, mice
were challenged by an intraperitoneal injection of insulin
and serum glucose levels were measured. Our results
showed that in comparison to control mice, blood glucose
levels in Pdx1-Cre
early;Smo
ﬂox/null mice were signiﬁcantly
lower and took longer to recover (Fig. 6B), indicating that
they do not have peripheral tissue defects in sensing
insulin and were, in fact, more insulin sensitive. Impor-
tantly, we did not detect any signiﬁcant differences in total
body weight in Pdx1-Cre
early;Smo
ﬂox/null mice when com-
pared with controls, excluding the possibility that an
decrease in body mass might lead to improved insulin
sensitivity (supplemental Fig. 5A).
To determine whether insulin production is affected in
Pdx1-Cre
early;Smo
ﬂox/null pancreata, we analyzed Insulin
expression levels. Our results showed that Insulin gene
expression in islets was reduced by 40% (Fig. 6C), in
accordance with Insulin protein levels from total pancre-
ata that were diminished by the same amount (Fig. 6D). In
contrast to previous studies demonstrating a positive role
for Hh signaling on Insulin production through Pdx1
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FIG. 5. Adult histology in Pdx1-Cre
early;Smo
ﬂox/null mice is normal.
Hematoxylin and eosin staining in control (A) and Pdx1-Cre
early;
Smo
ﬂox/null (B) mice show normal histology. Immunostaining for pan-
creatic markers amylase (red) and mucin (green) (C and D), glucagon
(red) and insulin (green) (E and F), pancreatic polypeptide (red) and
somatostatin (green) (G and H), and insulin (red), Pdx1 (green), and
DAPI (blue) (I and J) show no apparent defects. Staining performed on
3-month-old pancreata. Scale bars in A–D are equal to 200 m, while
scale bars in E–H are equal to 100 m. Lastly, scale bars in I–J are
equal to 50 m. (A high-quality digital representation of this ﬁgure is
available in the online issue.)
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altered in Pdx1-Cre
early;Smo
ﬂox/null pancreata (Fig. 6C).
While Insulin gene and protein levels were diminished, we
did not detect any signiﬁcant differences in fasting serum
insulin levels (supplemental Fig. 5B). To assess insulin
secretion defects, we treated isolated islets to conditions
of low and high glucose and measured their corresponding
insulin secretion output. Indeed, in isolated islets, we
found impaired insulin secretion (Fig. 6E). However, when
comparing the level of insulin secreted from low to high
glucose levels in each group, control islets secreted two-
and-a-half times the baseline level of insulin in high-
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FIG. 6. Pdx1-Cre
early;Smo
ﬂox/null mice are glucose intolerant and produce and secrete less insulin. A: Pdx1-Cre
early;Smo
ﬂox/null mice fasted
overnight and challenged with 2 mg/kg of sterile glucose by intraperitoneal injection show glucose intolerance phenotypes at 3 months of age (n 
13; ***P < 5E
5, two-way ANOVA, a measure of statistical signiﬁcance for whole datasets). B: Pdx1-Cre
early;Smo
ﬂox/null mice fasted overnight and
challenged with 1 unit/kg of sterile insulin by intraperitoneal injection are more insulin sensitive than control mice (n  5; ***P < 5E
5, two-way
ANOVA). C: Sybr Green real-time PCR shows that while Pdx1 expression is not changed, Insulin expression is downregulated by nearly 40% in
adult islets (n  3; *P < 0.05). D: Insulin content from total pancreata is reduced by nearly 40% (n  4; **P < 0.02). In vitro insulin secretion
assays from isolated islets under high glucose (300 mg/dl) conditions vs. low glucose (30 mg/dl) conditions in the absence (E)( n  3; ***P < 0.005,
**P < 0.02) or presence (F) of 40 mmol/l potassium chloride (n  3; *P < 0.05). G: Quantiﬁcation of -cell mass shows increased -cell mass in
Pdx1-Cre
early;Smo
ﬂox/null mice (n  4; *P < 0.05). Unless otherwise indicated, P values were determined by Student t test.
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early;Smo
ﬂox/null islets
secreted four times the baseline level of insulin. Thus,
Pdx1-Cre
early;Smo
ﬂox/null islets secreted relatively more
insulin than control islets, indicative of impaired insulin
production rather than insulin secretion. To further rule
out a secretion defect, we performed insulin secretion
assays in the presence of potassium chloride (KCl), a
known stimulator of insulin secretion. We found that in
low glucose conditions with KCl, Pdx1-Cre
early;Smo
ﬂox/null
islets secrete equivalent amounts of insulin as control
islets (Fig. 6F). But when challenged in high-glucose
conditions with KCl, Pdx1-Cre
early;Smo
ﬂox/null islets se-
crete comparatively less insulin than controls (Fig. 6F).
Together, these results indicate that while mutant islets
are capable of increasing secretion of insulin, they have
deﬁciencies in meeting higher insulin demands due to
diminished insulin production capacity. To further inves-
tigate the possible causes of the defects in insulin synthe-
sis and secretion, we analyzed the expression of -cell
genes that are important for -cell physiology. We found
that gene expression for a number of -cell genes, includ-
ing Glut2, Glucokinase, and NeuroD1, were normal (sup-
plemental Fig. 4A). Gene expression analysis for secretory
pathway components, including Kir6.2, SUR1, Calpain10,
and SNAP25, were also normal (supplemental Fig. 4B).
Glucose intolerance caused by reduced insulin produc-
tion may also be a result of reduced -cell mass. To
determine whether -cell mass is altered in adult mice, we
measured -cell mass in Pdx1-Cre
early;Smo
ﬂox/null versus
control mice. Surprisingly, we found that -cell mass in
Pdx1-Cre
early;Smo
ﬂox/null mice was actually increased
nearly twofold (Fig. 6G). Collectively, these data indicate
that Pdx1-Cre
early;Smo
ﬂox/null pancreata try to compensate
for reduced insulin production levels by increasing -cell
mass. Considering these results, we conclude that adult
Pdx1-Cre
early;Smo
ﬂox/null mice have normal pancreas mor-
phology but impaired -cell function due to reduced
insulin production despite increased -cell mass.
DISCUSSION
Understanding proper -cell formation and function are
imperative to ﬁnding treatments and cures for -cell
pathologies such as diabetes. Currently, it is accepted that
Shh expression must be excluded from the budding mouse
pancreatic epithelium. However the subsequent expres-
sion of Hh signaling components later during pancreas
formation suggest that there may be a functional require-
ment for Hh signaling during pancreas morphogenesis. In
this study, we examined the requirement for epithelial Hh
signaling in the developing pancreas. Apelqvist et al. (9)
showed that Ptch1 is not expressed in e9.5 pancreatic
epithelium. Through Ptch1-LacZ staining, we show that
Ptch1 expression is detectable by e10.5, indicating that
Hh-active cells reside in the pancreatic epithelium soon
after pancreas speciﬁcation. While the number of Ptch1-
LacZ–positive cells expands during development, the ex-
pression levels are low and positive cells are restricted to
the ductal and endocrine compartments. In contrast, after
birth, Ptch1-LacZ–positive cells stain robustly in the islets
and ducts, suggesting that the level of Hh signaling after
birth is higher than in utero.
During early stages, we also ﬁnd some Ptch1-LacZ–
positive cells in the neighboring pancreatic mesenchyme.
Epithelial-mesenchymal crosstalk is important for proper
organ formation, and Hh signaling may function differently
in either compartments. To address the functional require-
ment of Hh signaling in the pancreas epithelium, we
generated Pdx1-Cre
early;Smo
ﬂox/null mice, which sufﬁ-
ciently lose Smo expression and Hh signaling speciﬁcally
in the epithelial compartment of the organ. The ﬁnding
that Hh signaling is required for proper early epithelial
expansion and branching in developing pancreata is con-
trary to previous studies (9–15) that suggested that Hh
signaling inhibits mammalian pancreas growth. However,
prior studies focused on ectopic activation of Hh ligand
expression and the negative effects observed on pancreas
development resulted from perturbing the epithelial-mes-
enchymal crosstalk required for proper organ formation.
Moreover, previous studies emphasize that the inhibitory
effects of Hh signaling is primarily responsible for estab-
lishing the pancreas organ boundaries in the foregut. Our
results extend this model by demonstrating an additional
role for low-level Hh signaling that promotes the early
expansion of pancreatic epithelium by e12.5. Evidence for
Hh signaling as mediator of cell proliferation has been
broadly noted (4,5). Surprisingly, Hh activity appears to
block proliferation of other pancreatic epithelial cells at
midgestation, suggesting temporally distinct roles during
pancreas formation. Thus, while our data point to Hh
signaling as a mediator of cell proliferation during pan-
creas development, the exact mechanisms by which the
pathway regulates epithelial proliferation in a transient
and dynamic manner need to be explored further.
In addition to impaired pancreas morphogenesis, Pdx1-
Cre
early;Smo
ﬂox/null mice have delayed -cell development.
This conclusion is based on the results that the insulin-
positive -cell area was reduced, but -cell progenitor
numbers were increased at e15.5, and the full complement
of -cells was established at the end of gestation. More-
over, albeit not conclusive, temporal analysis of Ngn3
expression indicated a trend whereby peak expression of
Ngn3/endocrine neogenesis was delayed. This suggests a
temporary delay in general endocrine cell development in
Pdx1-Cre
early;Smo
ﬂox/null mice that is overcome with time.
In support of this notion is the observation that the
number of -cells, which form earlier than -cells during
normal pancreas organogenesis, was unchanged at e15.5
compared with controls.
Our studies in mice complement Zebraﬁsh work that has
demonstrated the requirement for Hh signaling during
gastrulation, a developmental stage that precedes the
onset of organ formation. In Zebraﬁsh, inhibition of Hh
signaling at early gastrulation stages blocks the formation
of pancreatic endocrine cells (37,38). Interestingly, this
requirement for Smo function is non-cell autonomous (37).
Later during gastrulation, inhibition of Hh signaling in-
creases the formation of insulin-producing cells (39).
While the relationship of Hh signaling during mouse
gastrulation and subsequent pancreatic endocrine cell
formation has not been elucidated, our present work and
the studies in Zebraﬁsh support the notion that the level
and timing of Hh signaling need to be closely regulated to
allow proper endocrine cell development.
Adult Pdx1-Cre
early;Smo
ﬂox/null mice possess normal
pancreas morphology, while the -cells are dysfunctional.
Although these mice are sensitive to exogenous insulin
and have an increased -cell mass, their -cells produce
less insulin, resulting in reduced insulin secretion and a
glucose intolerance phenotype. Importantly, our data indi-
cate that the primary defect lies within the production of
insulin whereas secretion appears intact. Thomas and
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activity by increasing insulin production and secretion
through regulation of Pdx1 expression. Although we did
not detect signiﬁcant changes in Pdx1 transcription by
RT-PCR or in Pdx1 protein levels by qualitative staining in
mutant mice, Insulin expression was reduced and isolated
islets recapitulated decreased insulin secretion in culture.
While further studies are needed, this suggests a mecha-
nism independent of Pdx1 regulation on Insulin transcrip-
tion for Hh-regulated insulin production. The differences
observed between the previous cell culture experiments
and our in vivo analysis maybe due to the inherent altered
state of insulinoma cell lines versus the native -cell.
Nevertheless, both studies emphasize the role of Hh
signaling in maintaining proper insulin production. Fur-
ther support comes from the ﬁnding that Ptch1-LacZ
expression, indicative of Hh signaling activity, becomes
dramatically stronger in postnatal islets at a time when the
demand for -cell functionality and insulin activity begins.
Interestingly, Pdx1-Cre
early;Smo
ﬂox/null mice are more
insulin sensitive. While we do not understand the mecha-
nisms that result in this change, these data rule out
impaired insulin sensitivity as a cause for glucose intoler-
ance phenotypes in Pdx1-Cre
early;Smo
ﬂox/null mice. Cou-
pled with data demonstrating that insulin secretion is
intact, these results emphasize that the primary defect in
Pdx1-Cre
early;Smo
ﬂox/null mice lies in insulin production in
-cells.
It should be noted that previous studies have linked Hh
signaling to the formation and progression of pancreatic
adenocarcinoma (40–47). During neoplastic transforma-
tion, excessive Hh ligands secreted from the tumorigenic
epithelium (41,42) are likely to act predominately on the
surrounding stroma in a paracrine manner (40,46,47). In
the endocrine compartment, previous work (13,16) has
shown expression of Hh ligands, Ihh and Dhh, in pancre-
atic islet cells. Unfortunately, due to the absence of agents
suitable for cell type–speciﬁc expression analysis, the
exact complement of those cells within the islets that
produce and secrete ligands is currently missing. Thus,
while our work and work from others indicate that epithe-
lial-derived -cells respond to Hh ligands in a juxtacrine or
autocrine fashion, unequivocal resolution of this question
awaits additional experiments with improved reagents.
As we struggle to ﬁnd potential treatments and cures for
diabetes, the need to generate or expand more functional
-cells remains unrequited. Understanding the mecha-
nisms that will allow us to generate and sustain -cell
populations and function is imperative. Data presented
here demonstrate that epithelial Hh signaling is important
during pancreas development and in maintaining insulin
production in the adult -cell, thus adding another layer to
the current perspective that views Hh inhibition as impor-
tant for the generation of functional pancreas endocrine
cells.
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